210 related articles for article (PubMed ID: 19710627)
1. Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease.
Meehan DT; Delimont D; Cheung L; Zallocchi M; Sansom SC; Holzclaw JD; Rao V; Cosgrove D
Kidney Int; 2009 Nov; 76(9):968-76. PubMed ID: 19710627
[TBL] [Abstract][Full Text] [Related]
2. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
Zeisberg M; Khurana M; Rao VH; Cosgrove D; Rougier JP; Werner MC; Shield CF; Werb Z; Kalluri R
PLoS Med; 2006 Apr; 3(4):e100. PubMed ID: 16509766
[TBL] [Abstract][Full Text] [Related]
3. Laminin α2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis.
Delimont D; Dufek BM; Meehan DT; Zallocchi M; Gratton MA; Phillips G; Cosgrove D
PLoS One; 2014; 9(6):e99083. PubMed ID: 24915008
[TBL] [Abstract][Full Text] [Related]
4. Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease.
Dufek B; Meehan DT; Delimont D; Cheung L; Gratton MA; Phillips G; Song W; Liu S; Cosgrove D
Kidney Int; 2016 Aug; 90(2):300-310. PubMed ID: 27165837
[TBL] [Abstract][Full Text] [Related]
5. Synaptopodin deficiency exacerbates kidney disease in a mouse model of Alport syndrome.
Ning L; Suleiman HY; Miner JH
Am J Physiol Renal Physiol; 2021 Jul; 321(1):F12-F25. PubMed ID: 34029143
[TBL] [Abstract][Full Text] [Related]
6. Integrin alpha1beta1 regulates matrix metalloproteinases via P38 mitogen-activated protein kinase in mesangial cells: implications for Alport syndrome.
Cosgrove D; Meehan DT; Delimont D; Pozzi A; Chen X; Rodgers KD; Tempero RM; Zallocchi M; Rao VH
Am J Pathol; 2008 Mar; 172(3):761-73. PubMed ID: 18258846
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.
Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT
Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763
[TBL] [Abstract][Full Text] [Related]
8. α1β1 integrin/Rac1-dependent mesangial invasion of glomerular capillaries in Alport syndrome.
Zallocchi M; Johnson BM; Meehan DT; Delimont D; Cosgrove D
Am J Pathol; 2013 Oct; 183(4):1269-1280. PubMed ID: 23911822
[TBL] [Abstract][Full Text] [Related]
9. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.
Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR
PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390
[TBL] [Abstract][Full Text] [Related]
10. Laminin-1 reexpression in Alport mouse glomerular basement membranes.
Abrahamson DR; Prettyman AC; Robert B; St John PL
Kidney Int; 2003 Mar; 63(3):826-34. PubMed ID: 12631063
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS).
Rao VH; Lees GE; Kashtan CE; Nemori R; Singh RK; Meehan DT; Rodgers K; Berridge BR; Bhattacharya G; Cosgrove D
Kidney Int; 2003 May; 63(5):1736-48. PubMed ID: 12675849
[TBL] [Abstract][Full Text] [Related]
12. Ramipril therapy in integrin α1-null, autosomal recessive Alport mice triples lifespan: mechanistic clues from RNA-seq analysis.
Madison J; Wilhelm K; Meehan DT; Gratton MA; Vosik D; Samuelson G; Ott M; Fascianella J; Nelson N; Cosgrove D
J Pathol; 2024 Mar; 262(3):296-309. PubMed ID: 38129319
[TBL] [Abstract][Full Text] [Related]
13. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
[TBL] [Abstract][Full Text] [Related]
14. Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndrome.
Rao VH; Meehan DT; Delimont D; Nakajima M; Wada T; Gratton MA; Cosgrove D
Am J Pathol; 2006 Jul; 169(1):32-46. PubMed ID: 16816359
[TBL] [Abstract][Full Text] [Related]
15. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase dysregulation in the stria vascularis of mice with Alport syndrome: implications for capillary basement membrane pathology.
Gratton MA; Rao VH; Meehan DT; Askew C; Cosgrove D
Am J Pathol; 2005 May; 166(5):1465-74. PubMed ID: 15855646
[TBL] [Abstract][Full Text] [Related]
17. Mild electrical stimulation and heat shock ameliorates progressive proteinuria and renal inflammation in mouse model of Alport syndrome.
Koga T; Kai Y; Fukuda R; Morino-Koga S; Suico MA; Koyama K; Sato T; Shuto T; Kai H
PLoS One; 2012; 7(8):e43852. PubMed ID: 22937108
[TBL] [Abstract][Full Text] [Related]
18. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
[TBL] [Abstract][Full Text] [Related]
19. Activation of Stimulator of IFN Genes (STING) Causes Proteinuria and Contributes to Glomerular Diseases.
Mitrofanova A; Fontanella A; Tolerico M; Mallela S; Molina David J; Zuo Y; Boulina M; Kim JJ; Santos J; Ge M; Sloan A; Issa W; Gurumani M; Pressly J; Ito M; Kretzler M; Eddy S; Nelson R; Merscher S; Burke G; Fornoni A
J Am Soc Nephrol; 2022 Dec; 33(12):2153-2173. PubMed ID: 36198430
[TBL] [Abstract][Full Text] [Related]
20. Pathogenicity of a Human Laminin
Funk SD; Bayer RH; Malone AF; McKee KK; Yurchenco PD; Miner JH
J Am Soc Nephrol; 2018 Mar; 29(3):949-960. PubMed ID: 29263159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
